Dysregulated mTOR signaling occurs in a variety of lymphoproliferative disorders, including autoimmune lymphoproliferative syndrome (ALPS), a disorder of lymphocyte survival due to defective apoptosis hallmarked biologically by double negative T-cells (1). Here, MTOR is linked to autoimmune lymphoproliferative syndrome.